ALS systems biology study
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This study looks at the biology of amyotrophic lateral sclerosis (ALS) to better understand the disease. If you are a patient of Dr. Espíndola at UFSC, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a patient of Dr. Espíndola at UFSC.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens people with ALS to see if they might qualify for future gene-targeted treatments. It helps match you to trials that may be a good fit for your genetic type.
This study collects and stores medical information from people diagnosed with ALS or certain related conditions affecting movement. It may help researchers better understand how these illnesses change over time and improve future treatments.
This study looks at genetic risk for amyotrophic lateral sclerosis (ALS) in families. It may help researchers understand who carries ALS-related gene changes and how that affects future care.
This study is a research collaborative that collects information from people with ALS or their families. It aims to better understand the disease and find markers that could help develop treatments.
This study looks at people who might have amyotrophic lateral sclerosis (ALS) to understand what factors are associated with how the condition starts and develops. If you have a suspected or confirmed ALS diagnosis, it may help researchers learn what influences ALS and potentially guide future prevention or care.
This study follows people living with amyotrophic lateral sclerosis (ALS) over time. It may help researchers better understand ALS and track changes that could guide future treatments.
Hear when a new ALS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.